Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer. [electronic resource]
Producer: 20191209Description: e12821 p. digitalISSN:- 1365-3083
- Antineoplastic Agents, Immunological -- administration & dosage
- Autoimmunity -- drug effects
- Biomarkers, Tumor -- antagonists & inhibitors
- CTLA-4 Antigen -- antagonists & inhibitors
- Humans
- Lymphocyte Activation -- drug effects
- Molecular Targeted Therapy
- Neoplasm Metastasis
- Neoplasm Staging
- Neoplasms -- drug therapy
- Off-Label Use
- Proof of Concept Study
- Signal Transduction -- drug effects
- T-Lymphocytes -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.